By Anokhi Saklecha, CNN The first participants have been vaccinated in a Phase 1 clinical trial of an experimental HIV vaccine that utilizes Moderna’s mRNA technology, the company announced last week. The trial, titled IAVI G002, is being conducted in partnership IAVI, a nonprofit scientific researc…
KVIA El Paso's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
Moderna begins early-stage trials of mRNA-based HIV vaccine
Headline from Engadget ·
Newest
First patients vaccinated in clinical trial of HIV experimental vaccine that uses Moderna's mRNA technology
Testing in humans of an HIV vaccine that uses messenger RNA technology has begun, the biotech firm Moderna and the International AIDS Vaccine Initiative said Thursday.
Moderna announced last week that the first participants in its Phase 1 clinical trial of an experimental HIV vaccine have been vaccinated. The vaccine utilizes Moderna’s mRNA technology and is being conducted in partnership IAVI, a nonprofit scientific research organization.
The first participants have been vaccinated in a Phase 1 clinical trial of an experimental HIV vaccine that utilizes Moderna's mRNA technology, the company announced last week.
By Anokhi Saklecha, CNN The first participants have been vaccinated in a Phase 1 clinical trial of an experimental HIV vaccine that utilizes Moderna’s mRNA technology, the company announced last week. The trial, titled IAVI G002, is being conducted in partnership IAVI, a nonprofit scientific researc…
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
First patients vaccinated in clinical trial of HIV experimental vaccine that uses Moderna's mRNA technology | Since Then